VELO · Insider Trading
Velo3D, Inc. Common stock
Every open-market purchase and sale reported by VELO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Jason Michael Lloyd | Director | M | +1,960 | +$20.64K |
| 2026-09-15 | Adrian Keppler | Director | M | +1,960 | +$20.64K |
| 2026-09-15 | Stefan Krause | Director | M | +1,960 | +$20.64K |
| 2026-08-28 | Arun Jeldi | CEO | M | +3,146 | +$50.84K |
| 2026-06-16 | Lily Mei | Director | A | +7,843 deriv. | — |
| 2026-06-16 | Jason Michael Lloyd | Director | A | — | — |
| 2026-06-16 | Adrian Keppler | Director | A | — | — |
| 2026-06-16 | Stefan Krause | Director | A | — | — |
| 2026-05-29 | Jason Michael Lloyd | Director | M | +1,623 | +$41.87K |
| 2026-05-29 | Kenneth Dale Thieneman | Director | M | +1,623 | +$41.87K |
| 2026-05-18 | Arun Jeldi | CEO | M | +3,145 | +$62.40K |
| 2026-04-08 | James D Suva | CFO | A | +135,000 deriv. | — |
| 2026-03-30 | Stefan Krause | Director | M | +3,188 | +$31.88K |
| 2026-03-30 | Kenneth Dale Thieneman | Director | M | +3,188 | +$31.88K |
| 2026-03-30 | Adrian Keppler | Director | M | +3,188 | +$31.88K |
| 2026-03-06 | Kenneth Dale Thieneman | Director | A | +10,000,000 deriv. | — |
| 2026-03-06 | Arun Jeldi | CEO | C | +394,517 | +$6.46M |
| 2026-03-06 | Kenneth Dale Thieneman | Director | C | +1,145,830 | +$12.03M |
| 2026-02-18 | Jason Michael Lloyd | Director | Buy | +7,000 | +$27.39K |
| 2026-02-18 | Arun Jeldi | CEO | M | +12,583 | — |
| 2026-01-05 | Hull Hou Jun Xu | CFO | MIXED | +6,422 | +$93.57K |
| 2025-12-30 | Stefan Krause | Director | M | +3,188 | +$43.04K |
| 2025-12-30 | Adrian Keppler | Director | M | +3,188 | +$43.04K |
| 2025-12-30 | Jason Michael Lloyd | Director | M | +3,188 | +$43.04K |
| 2025-12-30 | Kenneth Dale Thieneman | Director | M | +3,188 | +$43.04K |
| 2025-11-20 | Hull Hou Jun Xu | CFO | MIXED | +2,236 | +$10.42K |
| 2025-10-01 | Stefan Krause | Director | M | +3,188 | +$9.60K |
| 2025-10-01 | Jason Michael Lloyd | Director | M | +3,188 | +$9.60K |
| 2025-10-01 | Hull Hou Jun Xu | CFO | MIXED | +2,237 | +$8.70K |
| 2025-10-01 | Adrian Keppler | Director | M | +3,188 | +$9.60K |
| 2025-10-01 | Kenneth Dale Thieneman | Director | M | +3,188 | +$9.60K |
| 2025-09-24 | Hull Hou Jun Xu | CFO | MIXED | +2,237 | — |
| 2025-09-23 | Stefan Krause | Director | A | +12,752 deriv. | — |
| 2025-09-23 | Adrian Keppler | Director | A | +12,752 deriv. | — |
| 2025-09-23 | Jason Michael Lloyd | Director | A | +12,752 deriv. | — |
| 2025-09-23 | Kenneth Dale Thieneman | Director | A | +12,752 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Arun Jeldi | CEO | 12,756,814 | $82.79M |
| Kenneth Dale Thieneman | Director | 1,157,017 | $7.51M |
| Jason Michael Lloyd | Director | 23,335 | $151.44K |
| Hull Hou Jun Xu | CFO | 17,178 | $111.49K |
| Stefan Krause | Director | 15,370 | $99.75K |
| Adrian Keppler | Director | 15,208 | $98.70K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VELO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.